Exagen Inc expected to post a loss of 50cents a share - Earnings Preview

Exagen

18/03/2022 20:34

* Exagen Inc  XGN.OQ   XGN.O  is expected to show a fall in
quarterly revenue when it reports  results on March 22. 
    * The Vista California-based  company is expected to report 
a
6.9% decrease in revenue to $11.8 million from $12.67 million a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Exagen Inc is for a
loss
of 50 cents per share. For the same quarter last year, the
company reported a loss of 27 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Exagen Inc
is
$23​, above​ its last closing price of $8.54. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.47       -0.46      -0.42     Beat    8.7
 Jun. 30 2021  -0.47       -0.44      -0.38     Beat    13
 Mar. 31 2021  -0.47       -0.47      -0.48     Missed  -2.3​
 Dec. 31 2020  -0.38       -0.41      -0.27     Beat    33.4
 ​​Sep.        -0.47       -0.47      -0.34     Beat    28.4
 30 2020                                                
 Jun. 30 2020  -0.75       -0.76      -0.27     Beat    64.4​
 Mar. 31 2020  -0.48       -0.49      -0.44     Beat    10.2
 Dec. 31 2019  -0.33       -0.37      -0.27     Beat    26.4
 This summary was machine generated March 18 at 20:34 GMT.  All
figures in US dollars  unless otherwise stated